Placebo buccal tablets
Sponsors
Sterotherapeutics LLC, Cairo University
Conditions
Cushing SyndromePremalignant Lesion
Phase 2
Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions.
CompletedNCT03208790
Start: 2017-09-30End: 2020-03-12Updated: 2021-04-20
A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy and Safety of Fluasterone Buccal Tablet in the Control of Hyperglycemia in Adults with Endogenous Cushing’s Syndrome
RecruitingCTIS2023-508322-10-00
Start: 2025-05-02Target: 24Updated: 2024-03-26